CY1107227T1 - Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ - Google Patents

Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ

Info

Publication number
CY1107227T1
CY1107227T1 CY20081100248T CY081100248T CY1107227T1 CY 1107227 T1 CY1107227 T1 CY 1107227T1 CY 20081100248 T CY20081100248 T CY 20081100248T CY 081100248 T CY081100248 T CY 081100248T CY 1107227 T1 CY1107227 T1 CY 1107227T1
Authority
CY
Cyprus
Prior art keywords
treatment
autoimmune diseases
ginseng extract
american ginseng
pq2d
Prior art date
Application number
CY20081100248T
Other languages
English (en)
Inventor
Larry Guilbert
Jacqueline J. Shan
Joanne Totosy De Zepetnek
Original Assignee
Fx Life Sciences International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fx Life Sciences International Gmbh filed Critical Fx Life Sciences International Gmbh
Publication of CY1107227T1 publication Critical patent/CY1107227T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

Η χρήση εκχυλισμάτων γκινσένγκ που χαρακτηρίζονται CVT-E002, PQ2, PQ2A, PQ2B, PQ2C, PQ2D και PQ223 στην παρασκευή μιας φαρμακευτικής σύνθεσης κατάλληλης για τη θεραπεία μιας αυτοάνοσης νόσου.
CY20081100248T 1999-02-25 2008-03-04 Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ CY1107227T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12196299P 1999-02-25 1999-02-25
PCT/US2000/002523 WO2000050054A1 (en) 1999-02-25 2000-02-25 Treatment of autoimmune diseases with american ginseng extract

Publications (1)

Publication Number Publication Date
CY1107227T1 true CY1107227T1 (el) 2012-01-25

Family

ID=22399768

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100248T CY1107227T1 (el) 1999-02-25 2008-03-04 Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ

Country Status (10)

Country Link
US (1) US8039027B1 (el)
EP (1) EP1161254B1 (el)
AT (1) ATE380555T1 (el)
AU (1) AU3478600A (el)
CY (1) CY1107227T1 (el)
DE (1) DE60037402T2 (el)
DK (1) DK1161254T3 (el)
ES (1) ES2295015T3 (el)
PT (1) PT1161254E (el)
WO (1) WO2000050054A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432454B1 (en) 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
AU2009219793B2 (en) 2008-02-29 2013-09-26 Afexa Life Sciences Inc. Activation of innate and adaptive immune responses by a ginseng extract
TW201613618A (en) * 2014-07-02 2016-04-16 Shaklee Corp Compositions and methods for enhancing immunity
CN106138139B (zh) * 2015-05-15 2020-07-28 富力 人参提取物、人参皂苷、人参皂苷衍生物在制备治疗巨细胞病毒感染病症的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6118722A (ja) * 1984-07-05 1986-01-27 Wakunaga Seiyaku Kk 生体防御能亢進剤
JPS61209599A (ja) * 1985-03-12 1986-09-17 Nitto Electric Ind Co Ltd 組織培養による多糖類の製造法
US5071839A (en) * 1987-11-02 1991-12-10 Yaguang Liu Safe pharmaceutical composition for decreasing side effects of antiviral drugs and increasing the immune function (SDI) II
JPH0245501A (ja) * 1988-08-06 1990-02-15 Wakunaga Pharmaceut Co Ltd 竹節ニンジン多糖およびその用途
JP2602295B2 (ja) * 1988-09-01 1997-04-23 宏 曳野 多糖類，その単離法および該多糖類を含む薬剤組成物
FR2648046B1 (fr) * 1989-05-26 1994-04-15 Arikhbaieff Nicolas Composition a base de ginseng pour le traitement d'un deficit immunitaire
CN1097605A (zh) * 1993-07-20 1995-01-25 包云喜 参硒口服蜜及其生产工艺
CN1205880A (zh) * 1996-01-23 1999-01-27 陈明 免疫防癌抗癌药物
JPH09241166A (ja) * 1996-03-06 1997-09-16 Kureha Chem Ind Co Ltd Ｈｓｐ６０ファミリーに属するタンパク質のジンセノサイド類含有合成抑制剤
JPH1036387A (ja) * 1996-07-25 1998-02-10 Kureha Chem Ind Co Ltd Ｈｓｐ２７ファミリーに属するタンパク質のジンセノサイド類含有合成抑制剤
US6432454B1 (en) * 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators

Also Published As

Publication number Publication date
DE60037402T2 (de) 2008-04-17
US8039027B1 (en) 2011-10-18
DK1161254T3 (da) 2008-05-05
WO2000050054A1 (en) 2000-08-31
EP1161254A4 (en) 2004-05-06
WO2000050054B1 (en) 2000-11-16
PT1161254E (pt) 2008-03-20
ES2295015T3 (es) 2008-04-16
EP1161254A1 (en) 2001-12-12
DE60037402D1 (de) 2008-01-24
ATE380555T1 (de) 2007-12-15
AU3478600A (en) 2000-09-14
EP1161254B1 (en) 2007-12-12

Similar Documents

Publication Publication Date Title
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
AR033555A1 (es) Producto para el tratamiento del carcinoma de receptor de estrogeno positivo, y uso de dicho producto para preparar medicamentos
DK1036058T3 (da) Adamantanderivater
DE69808130T2 (de) Adamantan-derivate
EE200100507A (et) Hüdroksümatairesinool vähkkasvaja vältimises
CY1105211T1 (el) Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
EE04852B1 (et) C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine ja ravimkoostise kasutamine vähkkasvajate või teiste proliferatiivsete haiguste ravimisel
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
CY1107672T1 (el) Φαρμακευτικες και/ή κοσμητικες συνθεσεις για τη θεραπεια εντοπισμενου αδιπικου ιστου και κυτταριτιδας
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
BR0210489A (pt) Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente
ATE255905T1 (de) Iscom oder iscom-matrix, welche einen gegen die schleimhaut gerichteten wirkstoff und ein antigen enthält
IT1305313B1 (it) 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
DOP2002000457A (es) Tetrahidroquinolinas
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
FR2845388B1 (fr) Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
ITMI20001257A0 (it) Composizione farmaceutica a base di prolina, glicina e lisina utile nella terapia per la cicatrizzazione delle ferite e delle lesioni tendin
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono